CONMED Crecimiento futuro
Future controles de criterios 3/6
Se prevé un crecimiento anual de los beneficios y los ingresos de CONMED de 27.7% y 7.5% por año respectivamente. Se prevé que el BPA crezca en un 26.6% al año. Se espera que la rentabilidad financiera sea de 15.9% en 3 años.
Información clave
27.7%
Tasa de crecimiento de los beneficios
26.6%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Medical Equipment | 16.5% |
| Tasa de crecimiento de los ingresos | 7.2% |
| Rentabilidad financiera futura | 15.9% |
| Cobertura de analistas | Good |
| Última actualización | 06 May 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching
Apr 18
Is CONMED (NYSE:CNMD) Using Too Much Debt?
Mar 28CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%
Feb 15US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results
Feb 03Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?
Jan 08Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects
Dec 18CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt
Nov 30Conmed: Sector Derating And A New Competitive Threat Shouldn't Overshadow A Solid Core Business
Oct 28Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?
Sep 22Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?
Aug 24Conmed: Reiterate Buy Rating As Earnings Are Expected To Grow Strongly
Jul 28Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?
Jun 08These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively
May 17Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)
Apr 28Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching
Mar 10Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden
Feb 14CONMED Non-GAAP EPS of $0.42 misses by $0.48, revenue of $250.9M misses by $51.58M
Feb 02Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)
Jan 24ConMed: Still Fairly Priced, Turning More Constructive
Dec 09At US$83.60, Is CONMED Corporation (NYSE:CNMD) Worth Looking At Closely?
Nov 18Conmed withdraws FY22 guidance on software implementation-related disruption
Nov 15CONMED (NYSE:CNMD) Has A Pretty Healthy Balance Sheet
Oct 11ConMed: Fairly Priced At Pre-Pandemic Market Cap
Sep 21CONMED (NYSE:CNMD) Has Announced A Dividend Of $0.20
Sep 03CONMED (NYSE:CNMD) Has Affirmed Its Dividend Of $0.20
Aug 18CONMED declares $0.20 dividend
Aug 11Should You Investigate CONMED Corporation (NYSE:CNMD) At US$98.47?
Jul 20We Think CONMED (NYSE:CNMD) Can Stay On Top Of Its Debt
Jun 23Here's Why I Think CONMED (NYSE:CNMD) Might Deserve Your Attention Today
Jun 10Estimating The Fair Value Of CONMED Corporation (NYSE:CNMD)
May 25Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2026 | 1,558 | 181 | 223 | 219 | 6 |
| 12/31/2025 | 1,451 | 147 | 207 | 186 | 8 |
| 12/31/2024 | 1,341 | 110 | 148 | 148 | 8 |
| 3/31/2024 | 1,262 | 82 | 142 | 158 | N/A |
| 12/31/2023 | 1,245 | 64 | 106 | 125 | N/A |
| 9/30/2023 | 1,169 | 58 | 38 | 57 | N/A |
| 6/30/2023 | 1,139 | 88 | 16 | 37 | N/A |
| 3/31/2023 | 1,099 | -94 | 7 | 29 | N/A |
| 12/31/2022 | 1,045 | -81 | 12 | 33 | N/A |
| 9/30/2022 | 1,069 | -83 | 59 | 79 | N/A |
| 6/30/2022 | 1,042 | -114 | 56 | 74 | N/A |
| 3/31/2022 | 1,020 | 68 | 74 | 90 | N/A |
| 12/31/2021 | 1,011 | 63 | 97 | 112 | N/A |
| 9/30/2021 | 989 | 62 | 83 | 98 | N/A |
| 6/30/2021 | 979 | 54 | 99 | 112 | N/A |
| 3/31/2021 | 881 | 13 | 70 | 83 | N/A |
| 12/31/2020 | 862 | 10 | 52 | 65 | N/A |
| 9/30/2020 | 874 | 0 | 69 | 85 | N/A |
| 6/30/2020 | 870 | 0 | 69 | 87 | N/A |
| 3/31/2020 | 951 | 34 | 84 | 103 | N/A |
| 12/31/2019 | 955 | 29 | 75 | 95 | N/A |
| 9/30/2019 | 933 | 29 | 60 | 79 | N/A |
| 6/30/2019 | 901 | 28 | 28 | 47 | N/A |
| 3/31/2019 | 876 | 31 | 29 | 46 | N/A |
| 12/31/2018 | 860 | 41 | 58 | 75 | N/A |
| 9/30/2018 | 840 | 72 | 55 | 71 | N/A |
| 6/30/2018 | 828 | 73 | 65 | 80 | N/A |
| 3/31/2018 | 812 | 71 | 61 | 75 | N/A |
| 12/31/2017 | 796 | 55 | N/A | 66 | N/A |
| 9/30/2017 | 778 | 15 | N/A | 58 | N/A |
| 6/30/2017 | 773 | 16 | N/A | 70 | N/A |
| 3/31/2017 | 769 | 12 | N/A | 72 | N/A |
| 12/31/2016 | 764 | 15 | N/A | 40 | N/A |
| 9/30/2016 | 750 | 16 | N/A | 36 | N/A |
| 6/30/2016 | 735 | 17 | N/A | 24 | N/A |
| 3/31/2016 | 722 | 22 | N/A | 17 | N/A |
| 12/31/2015 | 719 | 30 | N/A | 51 | N/A |
| 9/30/2015 | 723 | 34 | N/A | 64 | N/A |
| 6/30/2015 | 729 | 27 | N/A | 65 | N/A |
| 3/31/2015 | 736 | 30 | N/A | 63 | N/A |
| 12/31/2014 | 740 | 32 | N/A | 65 | N/A |
| 9/30/2014 | 747 | 31 | N/A | 67 | N/A |
| 6/30/2014 | 750 | 35 | N/A | 83 | N/A |
| 3/31/2014 | 753 | 34 | N/A | 93 | N/A |
| 12/31/2013 | 763 | 36 | N/A | 81 | N/A |
| 9/30/2013 | 756 | 37 | N/A | 88 | N/A |
| 6/30/2013 | 760 | 40 | N/A | 85 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (27.7% al año) de CNMD es superior a la tasa de ahorro (2.3%).
Beneficios vs. Mercado: Se prevé que los beneficios (27.7% al año) de CNMD crezcan más rápidamente que el mercado US (14.7% al año).
Beneficios de alto crecimiento: Se espera que los beneficios de CNMD crezcan significativamente en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (7.5% al año) de CNMD crezcan más despacio que el mercado de US (8.1% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 7.5% al año) de CNMD crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de CNMD sea baja dentro de 3 años (15.9%).